408 related articles for article (PubMed ID: 25465190)
1. Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors.
Palmerini E; Staals EL; Maki RG; Pengo S; Cioffi A; Gambarotti M; Picci P; Daolio PA; Parafioriti A; Morris C; Antonescu CR; Gronchi A; Casali PG; Donati DM; Ferrari S; Stacchiotti S
Eur J Cancer; 2015 Jan; 51(2):210-7. PubMed ID: 25465190
[TBL] [Abstract][Full Text] [Related]
2. Distinct extra-articular invasion patterns of diffuse pigmented villonodular synovitis/tenosynovial giant cell tumor in the knee joints.
Kim DE; Kim JM; Lee BS; Kim NK; Lee SH; Bin SI
Knee Surg Sports Traumatol Arthrosc; 2018 Nov; 26(11):3508-3514. PubMed ID: 29637236
[TBL] [Abstract][Full Text] [Related]
3. Giant cell tumor of tendon sheath, tenosynovial giant cell tumor, and pigmented villonodular synovitis: defining the presentation, surgical therapy and recurrence.
Martin RC; Osborne DL; Edwards MJ; Wrightson W; McMasters KM
Oncol Rep; 2000; 7(2):413-9. PubMed ID: 10671695
[TBL] [Abstract][Full Text] [Related]
4. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study.
Mastboom MJL; Palmerini E; Verspoor FGM; Rueten-Budde AJ; Stacchiotti S; Staals EL; Schaap GR; Jutte PC; Aston W; Gelderblom H; Leithner A; Dammerer D; Takeuchi A; Thio Q; Niu X; Wunder JS; ; van de Sande MAJ
Lancet Oncol; 2019 Jun; 20(6):877-886. PubMed ID: 31029509
[TBL] [Abstract][Full Text] [Related]
5. Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis.
Ravi V; Wang WL; Lewis VO
Curr Opin Oncol; 2011 Jul; 23(4):361-6. PubMed ID: 21577109
[TBL] [Abstract][Full Text] [Related]
6. A rare presentation of pigmented villonodular synovitis.
Hansen MA; Harper C; Yiannikas C; McGee-Collett M
J Clin Neurosci; 2007 Apr; 14(4):386-8. PubMed ID: 17240150
[TBL] [Abstract][Full Text] [Related]
7. Tenosynovial giant cell tumor: case report and review.
Lucas DR
Arch Pathol Lab Med; 2012 Aug; 136(8):901-6. PubMed ID: 22849738
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of the treatment of high-risk tenosynovial giant cell tumor/pigmented villonodular synovitis with radiotherapy and surgery.
Griffin AM; Ferguson PC; Catton CN; Chung PW; White LM; Wunder JS; Bell RS; O'Sullivan B
Cancer; 2012 Oct; 118(19):4901-9. PubMed ID: 22281719
[TBL] [Abstract][Full Text] [Related]
9. Recurrent pigmented villonodular synovitis and multifocal giant cell tumor of the tendon sheath: case report.
Wang JP; Rancy SK; DiCarlo EF; Wolfe SW
J Hand Surg Am; 2015 Mar; 40(3):537-41. PubMed ID: 25577961
[TBL] [Abstract][Full Text] [Related]
10. Diffuse-type giant cell tumor: clinicopathologic and immunohistochemical analysis of 50 cases with extraarticular disease.
Somerhausen NS; Fletcher CD
Am J Surg Pathol; 2000 Apr; 24(4):479-92. PubMed ID: 10757395
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis.
Fiocco U; Sfriso P; Lunardi F; Pagnin E; Oliviero F; Scagliori E; Cozzi L; Vezzù M; Molena B; Scanu A; Panziera C; Nardacchione R; Rubaltelli L; Dayer JM; Calabrese F; Punzi L
Autoimmun Rev; 2010 Sep; 9(11):780-4. PubMed ID: 20620241
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.
Cassier PA; Gelderblom H; Stacchiotti S; Thomas D; Maki RG; Kroep JR; van der Graaf WT; Italiano A; Seddon B; Dômont J; Bompas E; Wagner AJ; Blay JY
Cancer; 2012 Mar; 118(6):1649-55. PubMed ID: 21823110
[TBL] [Abstract][Full Text] [Related]
13. Pigmented villonodular bursitis/diffuse giant cell tumor of the pes anserine bursa: a report of two cases and review of literature.
Maheshwari AV; Muro-Cacho CA; Pitcher JD
Knee; 2007 Oct; 14(5):402-7. PubMed ID: 17669658
[TBL] [Abstract][Full Text] [Related]
14. Diffuse pigmented villonodular synovitis (diffuse-type giant cell tumour) of the foot and ankle.
Stevenson JD; Jaiswal A; Gregory JJ; Mangham DC; Cribb G; Cool P
Bone Joint J; 2013 Mar; 95-B(3):384-90. PubMed ID: 23450025
[TBL] [Abstract][Full Text] [Related]
15. Tenosynovial giant cell tumour of brachial plexus.
Ye JM; Ye MJ; Rogers TW; Gonzales M; Lo P
J Clin Neurosci; 2014 Jun; 21(6):1070-2. PubMed ID: 24380756
[TBL] [Abstract][Full Text] [Related]
16. Burden of Illness Associated with Tenosynovial Giant Cell Tumors.
Burton TM; Ye X; Parker ED; Bancroft T; Healey J
Clin Ther; 2018 Apr; 40(4):593-602.e1. PubMed ID: 29580718
[TBL] [Abstract][Full Text] [Related]
17. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides.
Cupp JS; Miller MA; Montgomery KD; Nielsen TO; O'Connell JX; Huntsman D; van de Rijn M; Gilks CB; West RB
Am J Surg Pathol; 2007 Jun; 31(6):970-6. PubMed ID: 17527089
[TBL] [Abstract][Full Text] [Related]
18. Pigmented villonodular synovitis.
Mendenhall WM; Mendenhall CM; Reith JD; Scarborough MT; Gibbs CP; Mendenhall NP
Am J Clin Oncol; 2006 Dec; 29(6):548-50. PubMed ID: 17148989
[TBL] [Abstract][Full Text] [Related]
19. The management of diffuse-type giant cell tumour (pigmented villonodular synovitis) and giant cell tumour of tendon sheath (nodular tenosynovitis).
van der Heijden L; Gibbons CL; Dijkstra PD; Kroep JR; van Rijswijk CS; Nout RA; Bradley KM; Athanasou NA; Hogendoorn PC; van de Sande MA
J Bone Joint Surg Br; 2012 Jul; 94(7):882-8. PubMed ID: 22733940
[TBL] [Abstract][Full Text] [Related]
20. Diffuse pigmented villonodular synovitis: preliminary results with intralesional resection and p32 synoviorthesis.
Ward WG; Boles CA; Ball JD; Cline MT
Clin Orthop Relat Res; 2007 Jan; 454():186-91. PubMed ID: 16906091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
